Form 4: Natera Co-Founder Sells Shares for Tax Obligations
Insider Transaction Report
Jonathan Sheena, Natera's Co-Founder and Director, sold 435 shares of common stock to cover tax obligations related to RSU vesting.
Summary
- Jonathan Sheena, Co-Founder and Director of Natera, Inc. (NTRA), reported a sale of common stock.
- The transaction involved the disposition of 435 shares of Natera common stock.
- The sale occurred on February 3, 2026, at a price of $230.768 per share.
- The purpose of the sale was to satisfy tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
- This transaction was executed under a Rule 10b5-1(c) plan, established on January 31, 2025.
- Following the transaction, Jonathan Sheena directly beneficially owns 263,161 shares of common stock.
- Additionally, 21,782 shares are indirectly held by Caraluna 1 Trust and 21,782 shares by Caraluna 2 Trust, for which the reporting person disclaims beneficial ownership.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale is explicitly for tax obligations related to RSU vesting and executed under a pre-arranged 10b5-1 plan, which is a common practice for executives.
Positives
- The sale was for tax obligations, indicating a non-discretionary reason rather than a lack of confidence in the company.
- The transaction was executed under a Rule 10b5-1 plan, demonstrating pre-planning and adherence to insider trading regulations.
Negatives
- A reduction in direct beneficial ownership by a co-founder and director, albeit for tax purposes.
Future Outlook
na
Industry Context
StockSavvy.ai notes that insider sales for tax withholding purposes are a routine occurrence in the biotechnology and diagnostics industry, particularly for executives with significant RSU grants. This transaction does not inherently signal a change in company fundamentals or management's long-term outlook, but rather a standard financial planning event.
Related Party Transactions
- Indirect beneficial ownership of 21,782 shares each by Caraluna 1 Trust and Caraluna 2 Trust, for which the reporting person disclaims beneficial ownership, represents a related party holding.
Stakeholder Impact
- Minimal impact on shareholders due to the small number of shares sold for a routine tax obligation.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2025-01-31 | Date of RSU grant and establishment of the written instruction for sale under Rule 10b5-1(c). |
| 2026-02-03 | Date of the reported transaction (sale of common stock). |
| 2026-02-04 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Natera, NTRA, Jonathan Sheena, Insider Trading, Form 4, Stock Sale, RSU Vesting, Tax Obligations, 10b5-1 Plan, Director, Co-Founder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.